Cannabics Pharmaceuticals Inc. (CNBX) financial statements (2022 and earlier)

Company profile

Business Address #3 BETHESDA METRO CENTER
BETHESDA, MD 20814
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7861,3867783,5221,3943,36819
Cash and cash equivalents7861,3867782661,3943,36819
Short-term investments   3,256   
Prepaid expense1782041522842271503
Advance royalties   500   
Total current assets:9651,5919304,3071,6213,51722
Noncurrent Assets
Property, plant and equipment5926438631,0029741202
Long-term investments and receivables    590  
Long-term investments    590  
Advance royalties   3,863   
Other undisclosed noncurrent assets5648454276,011   
Total noncurrent assets:1,1561,4881,28910,8761,5641202
TOTAL ASSETS:2,1203,0792,21915,1833,1853,63824
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:200178231215316387265
Other undisclosed accounts payable and accrued liabilities200178231215316387265
Debt1,069872     
Derivative instruments and hedges, liabilities     661
Due to related parties224224224224224246224
Other undisclosed current liabilities     0 
Total current liabilities:1,4931,273455439539699491
Noncurrent Liabilities
Total liabilities:1,4931,273455439539699491
Stockholders' equity
Stockholders' equity attributable to parent, including:6271,8061,76514,7442,6462,939(467)
Common stock14141413121211
Additional paid in capital17,48917,06315,37215,3009,8406,4471,108
Accumulated other comprehensive income (loss)(2,187)(1,906)(2,774)2,810   
Accumulated deficit(18,149)(16,826)(13,631)(6,164)(7,297)(3,520)(1,586)
Other additional capital3,4603,4602,7842,78490  
Other undisclosed stockholders' equity attributable to parent   (0)  0
Total stockholders' equity:6271,8061,76514,7442,6462,939(467)
TOTAL LIABILITIES AND EQUITY:2,1203,0792,21915,1833,1853,63824

Income statement (P&L) ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Revenues196196710106113
Gain on disposition of assets for financial service operations 196   
Gross profit: 196710106113
Operating expenses(3,051)(2,600)(3,051)(3,313)(3,818)(1,860)(393)
Other undisclosed operating income (loss) (196)0 (0)  
Operating loss:(3,051)(2,600)(3,043)(3,304)(3,809)(1,854)(281)
Nonoperating income (expense)(812)(594)(4,424)4,579 (69)(28)
Other nonoperating income (expense)(812)(594)(4,424)4,437 (80)(27)
Interest and debt expense (2)(8) (1)(4)(7)
Other undisclosed loss from continuing operations before equity method investments, income taxes(2)      
Income (loss) before gain (loss) on sale of properties:(3,865)(3,197)(7,476)1,275(3,810)(1,927)(316)
Other undisclosed net income (loss)   3,08833(7) 
Net income (loss):(3,865)(3,197)(7,476)4,363(3,777)(1,934)(316)
Other undisclosed net income (loss) attributable to parent228(3,230)  9
Net income (loss) available to common stockholders, diluted:(3,863)(3,194)(7,467)1,133(3,777)(1,934)(307)

Comprehensive Income ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Net income (loss):(3,865)(3,197)(7,476)4,363(3,777)(1,934)(316)
Other comprehensive income610      
Other undisclosed comprehensive loss(1,005)      
Comprehensive income (loss):(4,259)(3,197)(7,476)4,363(3,777)(1,934)(316)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,999871(5,576)(420)   
Comprehensive income (loss), net of tax, attributable to parent:(2,261)(2,326)(13,052)3,943(3,777)(1,934)(316)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: